Pharmaceutical Technology

MAY 2, 2023

IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines. Oncolytic viruses, cytokines, and therapeutic vaccines currently play a very minimal role in oncology treatment, with substantial efficacy still to be demonstrated for these classes.

Physicians 52

Physicians Marketing Patients Manufacturing 52

Clarify Health

FEBRUARY 13, 2024

Some sentiment analysis tools connect directly with applications like Zendesk and automatically tag support tickets. Growth teams often use sentiment analysis tools to identify these patterns and trends. Other sentiment analysis tools sift through social media posts and other places a healthcare provider or brand is mentioned online.

Healthcare 52

Healthcare Healthcare Media Healthcare Provider 52

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

Celeritas

SEPTEMBER 25, 2022

These badges or ID tags are currently widely integrated into pet collars. This means they need to have special measures at hand to deal with unusual behavior from their residents. Dynamic QR code badges can show anyone an animal’s patient number and family contact. They’re ideal for monitoring untrained pets that tend to wander off.

Insurance 52

Insurance Management Medical Doctors 52

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Despite the limited market, the price tags of haemophilia make it potentially lucrative. Haemophilia B is a rare condition.

Patients 98

Patients Food and Drug Administration Engineering Sales 98

pharmaphorum

AUGUST 26, 2022

BioMarin will no doubt have an eye on the earlier experience of bluebird bio, which secured EU approval for rare disease gene therapy Zynteglo (betibeglogene autotemcel) in 2019 for beta thalassaemia with a price tag of around €1.6 million spread over five years.

FDA 109

FDA Marketing Competition Patients 109

European Pharmaceutical Review

JULY 11, 2022

is designed to focus the immune response on parts of RBD shared by all viruses in the Severe Acute Respiratory Syndrome (SARS)-like Betacoronavirus family. These coronavirus RBDs are attached to a nanoparticle by protein tags, enabling the structure to display fragments from multiple viruses on a single nanoparticle. .

Manufacturing 90

Manufacturing Engineering Leads Medicine 90